Filing Details

Accession Number:
0001415889-24-002757
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-05 21:12:16
Reporting Period:
2024-02-02
Accepted Time:
2024-02-05 21:12:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM Pharmaceutical Preparations (2834) 831281555
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780069 Pamela Vig C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-02-02 1,214 $26.19 28,691 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 75,000 Indirect By The Vig-Ancock Family Trust
Footnotes
  1. Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.